Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 27, 806-810, April 1, 1967]
© 1967 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tassoni, E. M.
Right arrow Articles by Kravitz, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tassoni, E. M.
Right arrow Articles by Kravitz, B.

Cytogenetic Studies in Multiple Myeloma: A Study of Fourteen Cases1

Ernest M. Tassoni, John R. Durant2, Sharon Becker and Barbara Kravitz

The Departments of Pathology and Medicine, Temple University Health Sciences Center, Philadelphia, Pennsylvania 19140

The bone marrows of fourteen patients with multiple myeloma containing a total of more than twenty scroable metaphase plates in all samples collected were subjected to cytogenetic study. In five of these an abnormal acrocentric marker chromosome with long arms the length of those of the B group was found in a number of the hyperdiploid cells. In two additional patients, this same abnormality may have been present. A single patient had an abnormal submetacentric marker instead of the acrocentric one. Six patients had no abnormality. The incidence of abnormal karyotypes in the marrow of this series of myeloma patients is higher than previously reported and may reflect the result of evaluating a larger sample of cells in metaphase.

1 Supported by USPHS Grant #CA-08314-02.

2 Advanced Clinical Fellow of the American Cancer Society.

Received 11/15/66. Accepted 12/21/66.




This article has been cited by other articles:


Home page
ScienceHome page
T. Sugiyama, Y. Kurita, and Y. Nishizuka
Chromosome Abnormality in Rat Leukemia Induced by 7,12-Dimethylbenz[a]anthracene
Science, November 24, 1967; 158(3804): 1058 - 1059.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1967 by the American Association for Cancer Research.